The estimated Net Worth of Edward M Liddy is at least 3 百万$ dollars as of 14 August 2017. Mr. Liddy owns over 1,185 units of Abbott Laboratories stock worth over 2,677,952$ and over the last 21 years he sold ABT stock worth over 0$. In addition, he makes 325,910$ as Independent Director at Abbott Laboratories.
Edward has made over 10 trades of the Abbott Laboratories stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 1,185 units of ABT stock worth 58,018$ on 14 August 2017.
The largest trade he's ever made was exercising 646,788 units of Abbott Laboratories stock on 7 December 2006 worth over 24,888,402$. On average, Edward trades about 10,563 units every 23 days since 2003. As of 14 August 2017 he still owns at least 22,967 units of Abbott Laboratories stock.
You can see the complete history of Mr. Liddy stock trades at the bottom of the page.
Edward M. (Ed) Liddy serves as Independent Director of the Company. Mr. Liddy served as a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC from January 2010 to December 2015. At the request of the Secretary of the U.S. Department of Treasury, Mr. Liddy served as Interim Chairman and Chief Executive Officer of American International Group, Inc., a global insurance and financial services holding company, from September 2008 until August 2009. From January 1999 to April 2008, Mr. Liddy served as Chairman of the Board of the Allstate Corporation. He served as Chief Executive Officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and Chief Operating Officer from August 1994 to January 1999. Mr. Liddy currently serves on the Board of Directors of AbbVie Inc., 3M Company, and The Boeing Company. Mr. Liddy has reached the mandatory retirement age for directors at both Boeing and 3M and will not stand for re-election at either company's 2020 Annual Meeting. Through his executive leadership at Allstate and American International Group, and his board service at several Fortune 100 companies across a broad range of industries, Mr. Liddy provides valuable insights on corporate strategy, risk management, corporate governance and many other issues facing large, global enterprises. Additionally, as a former chief financial officer, audit committee chair at Goldman Sachs and 3M Company, and partner at Clayton, Dubilier & Rice, LLC, Mr. Liddy provides significant knowledge and understanding of corporate finance, capital markets, financial reports and accounting matters.
As the Independent Director of Abbott Laboratories, the total compensation of Edward Liddy at Abbott Laboratories is 325,910$. There are 18 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of 27,802,800$.
Edward Liddy is 73, he's been the Independent Director of Abbott Laboratories since 2010. There are 1 older and 42 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Edward's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 24 years, insiders at Abbott Laboratories have traded over 388,257,551$ worth of Abbott Laboratories stock and bought 1,028,477 units worth 44,923,618$ . The most active insiders traders include Miles D White、Richard A Gonzalez、Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of 4,003,344$. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth 3,100$.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: